8 search results
- Current search:
- Has podcast
- Blood disorders
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
Cochrane EvidencePublished 20 Apr 2017
Hydroxyurea (also known as hydroxycarbamide) for people with sickle cell disease
Review question What is the effect of hydroxyurea on clinical outcomes (changes in pain crises, life-threatening illnesses, survival, haemoglobin levels, quality of life and side effects) in people with sickle cell disease (SCD) of any genotype? Background SCD is an inherited genetic disorder that creates problems with haemoglobin (the substance ... -
Cochrane EvidencePublished 6 Oct 2016
Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications
Review question We wished to determine if any educational interventions have helped people with sickle cell disease and their caregivers to improve their understanding of the disease, recognize its complications, improve their adherence to treatment, affect how they utilize healthcare and improve other social and psychological problems that they might ... -
Cochrane EvidencePublished 4 Feb 2016
The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents
Review question: Is iron alone or iron as a supplement to erythropoiesis-stimulating agents (ESAs) superior to ESAs alone in the management of people diagnosed with chemotherapy-induced anemia (CIA)? Background: The current treatment of CIA is ESAs, which increase the production of red blood cells (erythropoiesis), and in some cases ESAs and iron. ... -
Cochrane EvidencePublished 30 Mar 2015
Strategies to increase the ownership and use of insecticide-treated bednets to prevent malaria
Researchers in the Cochrane Collaboration conducted a review of the effect of different strategies to increase people’s ownership and use of insecticide-treated bednets to prevent malaria. In February 2013 they identified 10 relevant studies. Their findings are summarized below. What is malaria and how can insecticide-treated bednets prevent it? Malaria ... -
Cochrane EvidencePublished 13 Jan 2015
Antimalarial drugs as a treatment of anaemia in children living in malaria-endemic areas.
Children living in malaria areas may develop severe anaemia, often caused by malaria infection, and this can cause death if not treated properly. Intermittent preventive treatment (IPT) is a course of malaria treatment given regularly to these children in order to prevent infection and malaria illness. It has been suggested that IPT could be used to ... -
Cochrane EvidencePublished 24 Apr 2014
Immune tolerance induction to destroy inhibitors in people with haemophilia A or B
Review question We reviewed evidence about the effect of immune tolerance induction to remove inhibitors in people with haemophilia A and B. Background Haemophilia A and B are inherited bleeding disorders, where affected people are missing a clotting factor in their blood, which is needed for normal blood clotting. Without this factor, people with ... -
Cochrane EvidencePublished 6 Jul 2011
Rapid diagnostic tests for diagnosing malaria
Fever is common in malarial areas, and getting the diagnosis right (ie deciding if it is due to malaria or other causes) and treating correctly helps save lives, particularly in children. The World Health Organization (WHO) now recommends that all patients with fever suspected of being malaria are properly diagnosed before any treatment begins. This ... -
Cochrane EvidencePublished 19 Oct 2005
Artemether-lumefantrine (six-dose regimen) for treating uncomplicated malaria
Using a pilot system we have categorised this review as: Current question - no update intended (topic covered in another review. Refer to: Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007483. DOI: 10.1002/14651858.CD007483.pub2.) ...
